{
    "root": "352f1797-e850-efb9-e063-6294a90a6442",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Meclizine Hydrochloride",
    "value": "20250515",
    "ingredients": [
        {
            "name": "D&C YELLOW NO. 10",
            "code": "35SW5USQ3G"
        },
        {
            "name": "FD&C YELLOW NO. 6",
            "code": "H77VEI93A8"
        },
        {
            "name": "HYPROMELLOSE 2910 (5 MPA.S)",
            "code": "R75537T0T4",
            "drugbank_id": "https://go.drugbank.com/drugs/DB11075"
        },
        {
            "name": "LACTOSE MONOHYDRATE",
            "code": "EWQ57Q8I5X",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_17716"
        },
        {
            "name": "MAGNESIUM STEARATE",
            "code": "70097M6I30",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14077"
        },
        {
            "name": "MICROCRYSTALLINE CELLULOSE",
            "code": "OP1R32D61U",
            "drugbank_id": "https://go.drugbank.com/drugs/DB14158"
        },
        {
            "name": "SILICON DIOXIDE",
            "code": "ETJ7Z6XBU4",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_30563"
        },
        {
            "name": "SODIUM STARCH GLYCOLATE TYPE A POTATO",
            "code": "5856J3G2A2",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_28017"
        },
        {
            "name": "MECLIZINE HYDROCHLORIDE",
            "code": "HDP7W44CIO",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31805"
        }
    ],
    "indications": {
        "text": "meclizine hydrochloride tablets indicated treatment vertigo associated diseases affecting vestibular system adults .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "contraindications": {
        "text": "recommended : 25 mg 100 mg daily , divided doses ( 2.1 ) . tablets : swallow whole ( 2.2 ) .",
        "doid_entities": [],
        "orphanet_entities": []
    },
    "warningsAndPrecautions": "16.1 supplied meclizine hydrochloride tablets usp , 25 mg light yellow yellow colored , spotted , oval shaped , biconvex uncoated tablets debossed '1162 ' one side plain side supplied follows : ndc 68071-3748-4 bottles 4 tablets child-resistance closure 16.2 storage handling store 20\u00b0 25\u00b0c ( 68\u00b0 77\u00b0f ) [ usp controlled room temperature ] . dispense tight , light-resistant container ( usp ) .",
    "adverseReactions": "meclizine hydrochloride tablets contraindicated patients hypersensitivity meclizine inactive ingredients [ ( 6 ) description ( 11 ) ] .",
    "indications_original": "Meclizine hydrochloride tablets are indicated for the treatment of vertigo associated with diseases affecting the vestibular system in adults.",
    "contraindications_original": "Recommended dosage: 25 mg to 100 mg daily, in divided doses ( 2.1 ). Tablets: Swallow whole ( 2.2 ).",
    "warningsAndPrecautions_original": "16.1 How Supplied\n                  \n                  Meclizine Hydrochloride Tablets USP, 25 mg are light yellow to yellow colored, spotted, oval shaped, biconvex uncoated tablets debossed with '1162' on one side and plain on the other side and are supplied as follows:\n                  NDC 68071-3748-4 in bottles of 4 tablets with child-resistance closure\n                  \n                  16.2 Storage and Handling\n                  Store at 20\u00b0 to 25\u00b0C (68\u00b0 to 77\u00b0F) [see USP Controlled Room Temperature].\n                  Dispense in a tight, light-resistant container (USP).",
    "adverseReactions_original": "Meclizine hydrochloride tablets are contraindicated in patients with a hypersensitivity to meclizine or any of the inactive ingredients\n \n  [see Adverse Reactions (\n  \n   6) and Description (\n  \n   11)].",
    "drug": [
        {
            "name": "Meclizine Hydrochloride",
            "chebi_id": "http://purl.obolibrary.org/obo/CHEBI_31805"
        }
    ]
}